Alyeska Investment Group’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-37,583
| Closed | -$898K | – | 1037 |
|
|
2021
Q1 | $898K | Sell |
37,583
-1,363,335
| -97% | -$25.3M | 0.01% | 605 |
|
|
2020
Q4 | $20.5M | Sell |
1,400,918
-113,680
| -8% | -$1.51M | 0.29% | 111 |
|
|
2020
Q3 | $21.5M | Buy |
1,514,598
+593,548
| +64% | +$9.07M | 0.33% | 95 |
|
|
2020
Q2 | $13.5M | Buy |
+921,050
| New | +$9.36M | 0.21% | 161 |
|
|
2020
Q1 | – | Sell |
-600,932
| Closed | -$2.89M | – | 521 |
|
|
2019
Q4 | $2.89M | Buy |
600,932
+52,490
| +10% | +$290K | 0.04% | 267 |
|
|
2019
Q3 | $3.32M | Buy |
548,442
+75,000
| +16% | +$468K | 0.05% | 257 |
|
|
2019
Q2 | $3.07M | Buy |
473,442
+30,300
| +7% | +$214K | 0.04% | 278 |
|
|
2019
Q1 | $3.14M | Sell |
443,142
-596,858
| -57% | -$3.93M | 0.04% | 256 |
|
|
2018
Q4 | $5.05M | Buy |
1,040,000
+648,091
| +165% | +$3.38M | 0.07% | 222 |
|
|
2018
Q3 | $2.88M | Sell |
391,909
-991,919
| -72% | -$7.28M | 0.03% | 276 |
|
|
2018
Q2 | $8.83M | Sell |
1,383,828
-102,662
| -7% | -$679K | 0.08% | 223 |
|
|
2018
Q1 | $8.09M | Sell |
1,486,490
-77,391
| -5% | -$385K | 0.07% | 249 |
|
|
2017
Q4 | $6.52M | Buy |
1,563,881
+550,000
| +54% | +$3.31M | 0.05% | 246 |
|
|
2017
Q3 | $9.76M | Buy |
1,013,881
+349,819
| +53% | +$3.63M | 0.07% | 244 |
|
|
2017
Q2 | $7.86M | Buy |
664,062
+486,627
| +274% | +$6.22M | 0.07% | 255 |
|
|
2017
Q1 | $2.27M | Sell |
177,435
-2,088
| -1% | -$25.1K | 0.02% | 388 |
|
|
2016
Q4 | $2.2M | Sell |
179,523
-114,290
| -39% | -$1.36M | 0.02% | 384 |
|
|
2016
Q3 | $3.47M | Buy |
293,813
+11,690
| +4% | +$113K | 0.03% | 348 |
|
|
2016
Q2 | $2.45M | Buy |
282,123
+5,725
| +2% | +$39.3K | 0.02% | 355 |
|
|
2016
Q1 | $1.46M | Buy |
276,398
+8,544
| +3% | +$47.6K | 0.01% | 347 |
|
|
2015
Q4 | $2.08M | Sell |
267,854
-116,478
| -30% | -$895K | 0.02% | 304 |
|
|
2015
Q3 | $3.02M | Buy |
384,332
+35,179
| +10% | +$325K | 0.04% | 302 |
|
|
2015
Q2 | $3.16M | Buy |
349,153
+101,566
| +41% | +$1.02M | 0.04% | 309 |
|
|
2015
Q1 | $3.21M | Sell |
247,587
-28,119
| -10% | -$368K | 0.04% | 322 |
|
|
2014
Q4 | $3.75M | Sell |
275,706
-87,989
| -24% | -$984K | 0.06% | 294 |
|
|
2014
Q3 | $3.26M | Sell |
363,695
-17,201
| -5% | -$185K | 0.07% | 260 |
|
|
2014
Q2 | $5.15M | Sell |
380,896
-1,828
| -0.5% | -$19.1K | 0.11% | 227 |
|
|
2014
Q1 | $3.8M | Buy |
382,724
+129,856
| +51% | +$1.61M | 0.1% | 222 |
|
|
2013
Q4 | $3.36M | Sell |
252,868
-258,606
| -51% | -$3.14M | 0.13% | 198 |
|
|
2013
Q3 | $6.21M | Buy |
511,474
+196,972
| +63% | +$2.11M | 0.25% | 127 |
|
|
2013
Q2 | $3.25M | Buy |
+314,502
| New | +$4.34M | 0.16% | 157 |
|
Alyeska Investment Group's GNMK Position: Q2 2021 in Review
Alyeska Investment Group sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 37,583 shares — an estimated $898K sold.
Alyeska Investment Group first reported a position in GNMK in Q2 2013 and held it in 31 quarters. The position peaked at $21.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Alyeska Investment Group reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Alyeska Investment Group sold 37,583 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $898K.
- Alyeska Investment Group first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 31 quarters.
- Alyeska Investment Group's GenMark Diagnostics, Inc position peaked at $21.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.